These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28733186)

  • 1. EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis.
    Luft T; Benner A; Jodele S; Dandoy CE; Storb R; Gooley T; Sandmaier BM; Becker N; Radujkovic A; Dreger P; Penack O
    Lancet Haematol; 2017 Sep; 4(9):e414-e423. PubMed ID: 28733186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation.
    Pedraza A; Salas MQ; Rodríguez-Lobato LG; Escribano-Serrat S; Suárez-Lledo M; Martínez-Cebrian N; Solano MT; Arcarons J; Rosiñol L; Gutiérrez-García G; Fernández-Avilés F; Moreno-Castaño AB; Molina P; Pino M; Carreras E; Díaz-Ricart M; Rovira M; Palomo M; Martínez C
    Transplant Cell Ther; 2024 Feb; 30(2):187.e1-187.e12. PubMed ID: 38000709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation.
    Varma A; Rondon G; Srour SA; Chen J; Ledesma C; Champlin RE; Ciurea SO; Saliba RM
    Biol Blood Marrow Transplant; 2020 May; 26(5):1013-1020. PubMed ID: 32045652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplantation EASIX Score Predicts Nonrelapse and Overall Mortality of Adult Patients Undergoing Single-Unit Unrelated Cord Blood Transplantation.
    Fujita S; Monna-Oiwa M; Kato S; Isobe M; Takahashi S; Nannya Y; Konuma T
    Transplant Cell Ther; 2023 Sep; 29(9):580.e1-580.e8. PubMed ID: 37402420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide.
    Mariotti J; Magri F; Giordano L; De Philippis C; Sarina B; Mannina D; Taurino D; Santoro A; Bramanti S
    Bone Marrow Transplant; 2023 Mar; 58(3):247-256. PubMed ID: 36414698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EASIX-1year and late mortality after allogeneic stem cell transplantation.
    Kordelas L; Terzer T; Gooley T; Davis C; Sandmaier BM; Sorror M; Penack O; Schaeper NDE; Blau IW; Beelen D; Radujkovic A; Dreger P; Luft T
    Blood Adv; 2023 Sep; 7(18):5374-5381. PubMed ID: 37477588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation.
    Sanchez-Escamilla M; Flynn J; Devlin S; Maloy M; Fatmi SA; Tomas AA; Escribano-Serrat S; Ponce D; Sauter CS; Giralt SA; Scordo M; Perales MA
    Bone Marrow Transplant; 2023 May; 58(5):498-505. PubMed ID: 36721042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EASIX and mortality after allogeneic stem cell transplantation.
    Luft T; Benner A; Terzer T; Jodele S; Dandoy CE; Storb R; Kordelas L; Beelen D; Gooley T; Sandmaier BM; Sorror M; Zeisbrich M; Radujkovic A; Dreger P; Penack O
    Bone Marrow Transplant; 2020 Mar; 55(3):553-561. PubMed ID: 31558788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation.
    Nawas MT; Sanchez-Escamilla M; Devlin SM; Maloy MA; Ruiz JD; Sauter CS; Giralt SA; Perales MA; Scordo M
    Blood Adv; 2022 Nov; 6(22):5898-5907. PubMed ID: 35977079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host Disease.
    Giesen N; Schwarzbich MA; Dischinger K; Becker N; Hummel M; Benner A; Radujkovic A; Müller-Tidow C; Dreger P; Luft T
    Transplantation; 2020 Nov; 104(11):2354-2359. PubMed ID: 31929430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EASIX for prediction of survival in lower-risk myelodysplastic syndromes.
    Merz A; Germing U; Kobbe G; Kaivers J; Jauch A; Radujkovic A; Hummel M; Benner A; Merz M; Dreger P; Luft T
    Blood Cancer J; 2019 Nov; 9(11):85. PubMed ID: 31712595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.
    Bartelink IH; Lalmohamed A; van Reij EM; Dvorak CC; Savic RM; Zwaveling J; Bredius RG; Egberts AC; Bierings M; Kletzel M; Shaw PJ; Nath CE; Hempel G; Ansari M; Krajinovic M; Théorêt Y; Duval M; Keizer RJ; Bittencourt H; Hassan M; Güngör T; Wynn RF; Veys P; Cuvelier GD; Marktel S; Chiesa R; Cowan MJ; Slatter MA; Stricherz MK; Jennissen C; Long-Boyle JR; Boelens JJ
    Lancet Haematol; 2016 Nov; 3(11):e526-e536. PubMed ID: 27746112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.
    Kennedy GA; Varelias A; Vuckovic S; Le Texier L; Gartlan KH; Zhang P; Thomas G; Anderson L; Boyle G; Cloonan N; Leach J; Sturgeon E; Avery J; Olver SD; Lor M; Misra AK; Hutchins C; Morton AJ; Durrant ST; Subramoniapillai E; Butler JP; Curley CI; MacDonald KPA; Tey SK; Hill GR
    Lancet Oncol; 2014 Dec; 15(13):1451-1459. PubMed ID: 25456364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EASIX (endothelial activation and stress index) predicts mortality in patients with coronary artery disease.
    Finke D; Hund H; Frey N; Luft T; Lehmann LH
    Clin Res Cardiol; 2024 Sep; ():. PubMed ID: 39256221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation.
    Peña M; Salas MQ; Mussetti A; Moreno-Gonzalez G; Bosch A; Patiño B; Jiménez L; Kara M; Parody R; Sureda A
    Blood Adv; 2021 Sep; 5(17):3418-3426. PubMed ID: 34495311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surrogates of Endothelial Injury Predict Survival After Post-transplant Cyclophosphamide.
    Baranwal A; Langer KJ; Kharfan-Dabaja MA; Ayala E; Foran J; Murthy H; Roy V; Iqbal M; Palmer J; Sproat LZ; Chhabra S; Khera N; Durani U; Hefazi M; Mangaonkar A; Shah MV; Litzow MR; Hogan WJ; Alkhateeb HB
    Transplant Cell Ther; 2024 Aug; ():. PubMed ID: 39154913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.
    Chen YB; Coughlin E; Kennedy KF; Alyea EP; Armand P; Attar EC; Ballen KK; Cutler C; Dey BR; Koreth J; McAfee SL; Spitzer TR; Antin JH; Soiffer RJ; Ho VT
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):981-7. PubMed ID: 23562738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study.
    Penack O; Luft T; Peczynski C; Benner A; Sica S; Arat M; Itäla-Remes M; Corral LL; Schaap NPM; Karas M; Raida L; Schroeder T; Dreger P; Metafuni E; Ozcelik T; Sandmaier BM; Kordelas L; Moiseev I; Schoemans H; Koenecke C; Basak GW; Peric Z
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.
    Luft T; Wendtner CM; Kosely F; Radujkovic A; Benner A; Korell F; Kihm L; Bauer MF; Dreger P; Merle U
    Front Immunol; 2021; 12():634416. PubMed ID: 34248931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.